Skip to main content
Year archive

BUKWANG PHARMACEUTICAL IND CO.,LTD — 2026 filings

All 18 regulatory filings released by BUKWANG PHARMACEUTICAL IND CO.,LTD (003000) in 2026, sourced directly from the official regulator.

18 Filings
2026 Period
2026 filings (18)
Filing Released Lang
분기보고서 (2026.03)
Interim / Quarterly Report Q1 2026
2026-05-14 Korean
[기재정정]타법인주식및출자증권취득결정
M&A Activity
2026-05-13 Korean
타법인주식및출자증권취득결정
M&A Activity
2026-04-27 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Q1 2026
2026-04-21 Korean
기업설명회(IR)개최(안내공시)
Investor Presentation
2026-04-15 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2026-03-24 Korean
기업가치제고계획(자율공시)
Capital/Financing Update
2026-03-24 Korean
사업보고서 (2025.12)
Annual Report FY 2025
2026-03-16 Korean
감사보고서제출
Audit Report / Information FY 2025
2026-03-16 Korean
주주총회소집공고
Proxy Solicitation & Information Statement
2026-03-09 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings
2026-02-27 Korean
대규모기업집단현황공시[분기별공시(개별회사용)]
Audit Report / Information Q1 2024
2026-02-27 Korean
주주총회소집결의
Proxy Solicitation & Information Statement
2026-02-23 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount
2026-02-23 Korean
지급수단별ㆍ지급기간별지급금액및분쟁조정기구에관한사항
Regulatory Filings
2026-02-13 Korean
매출액또는손익구조30%(대규모법인은15%)이상변경
Management Reports
2026-02-09 Korean
기업설명회(IR)개최(안내공시)
Investor Presentation
2026-02-02 Korean
투자판단관련주요경영사항
M&A Activity
2026-01-05 Korean